HCA Healthcare (NYSE:HCA) Price Target Raised to $400.00

HCA Healthcare (NYSE:HCA) had its target price raised by research analysts at Wells Fargo & Company from $395.00 to $400.00 in a report released on Wednesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 12.43% from the company’s previous close.

Several other brokerages have also weighed in on HCA. Morgan Stanley started coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Oppenheimer boosted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Finally, UBS Group upped their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $379.39.

HCA Healthcare Stock Performance

HCA traded down $10.89 during trading on Wednesday, hitting $355.77. The stock had a trading volume of 1,070,574 shares, compared to its average volume of 1,163,948. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a 50 day simple moving average of $392.01 and a 200-day simple moving average of $355.77. HCA Healthcare has a 12 month low of $226.48 and a 12 month high of $417.14. The firm has a market cap of $90.12 billion, a PE ratio of 15.68, a P/E/G ratio of 1.37 and a beta of 1.68.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the second quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $28,000. Bangor Savings Bank boosted its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Capital Performance Advisors LLP purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $41,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.